Projected Prevalence of Actionable Pharmacogenetic Variants and Level A Drugs Prescribed Among US Veterans Health Administration Pharmacy Users | Zendy

Catherine ChanfreauCoffinier | Zendy; Leland E. Hull | Zendy; Julie A. Lynch | Zendy; Scott L. DuVall | Zendy; Scott M. Damrauer | Zendy; Francesca Cunningham | Zendy; Benjamin F. Voight | Zendy; Michael E. Matheny | Zendy; David W. Oslin | Zendy; Michael Icardi | Zendy; Sony Tuteja | Zendy

Open Access

Projected Prevalence of Actionable Pharmacogenetic Variants and Level A Drugs Prescribed Among US Veterans Health Administration Pharmacy Users

Author(s) -

Catherine ChanfreauCoffinier,

Leland E. Hull,

Julie A. Lynch,

Scott L. DuVall,

Scott M. Damrauer,

Francesca Cunningham,

Benjamin F. Voight,

Michael E. Matheny,

David W. Oslin,

Michael Icardi,

Sony Tuteja

Publication year - 2019

Publication title -

jama network open

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.278

H-Index - 39

ISSN - 2574-3805

DOI - 10.1001/jamanetworkopen.2019.5345

Subject(s) - pharmacy , medicine , pharmacogenetics , medical prescription , family medicine , receipt , pharmacology , genotype , gene , genetics , biology , world wide web , computer science

This cross-sectional study uses 1000 Genomes Project data and US Veterans Health Administration demographic characteristics to project the number of veterans who carry an actionable pharmacogenetic variant and who have been prescribed 1 or more level A drugs that have well-established evidence of pharmacogenetic interactions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research